Emerging Targeted Therapies in Advanced Non-Small-Cell Lung Cancer

SIMPLE SUMMARY: The discovery of actionable oncogenic driver mutations in non-small-cell lung cancer (NSCLC) has revolutionized the treatment and prognosis of this dreadful disease. New targeted therapies are being developed and tested in early phase clinical trials rapidly. We summarize emerging fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shenduo, de Camargo Correia, Guilherme Sacchi, Wang, Jing, Manochakian, Rami, Zhao, Yujie, Lou, Yanyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251928/
https://www.ncbi.nlm.nih.gov/pubmed/37296863
http://dx.doi.org/10.3390/cancers15112899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251928/
https://www.ncbi.nlm.nih.gov/pubmed/37296863
http://dx.doi.org/10.3390/cancers15112899

Ejemplares similares